Allergan Plc: Will the Downtrend Continue for AGN Stock?

Despite chatter of a biotech acquisition and earnings Monday morning, the options market in AGN stock suggests normal event risk next week. More 

Biogen Inc (BIIB) Tacks on $7B in Market Value on Buyout Talk

Biogen Inc (NASDAQ:BIIB) just made a huge move out of thin air Tuesday evening, spiking 9.5% to $330 as of this writing. Until the surge, BIIB stock was trading in the red in the sub-$300 range. So why the sudden interest in this biotech? Well, those pesky “people familiar with the matter” are at it again,... More 

5 Smart Stock Buyback Plays

Now that earnings announcement season is ending, stock buybacks naturally pick up. Here's a quick list of five buyback plays to consider More 

Carl Icahn Takes Stake in Allergan plc Ordinary Shares (AGN) Stock

Allergan stock was up on Tuesday after news that Carl Icahn had taken a 'large' stake in the company, but details weren't revealed. More 

The 10 Best Healthcare Stocks to Buy Now

These companies are 10 of the best healthcare stocks to buy right now, as they should outperform in 2016's second half thanks to a few near-term catalysts. More 

This 4-Stock Dividend Retirement Portfolio Yields 7.3%

It's tough to build a dividend retirement portfolio that provides a decent yield these days, but with these 4 closed-end funds you get a strong start More 

Allergan: Why the Earnings Rally Is WAY Overdone for AGN Stock

Allergan (AGN) stock is soaring on Tuesday after an earnings beat and announcement of a huge stock buyback. But the rally is WAY overdone. More